| abstract |
This invention provides compounds defined by Formula I or a pharmaceutically acceptable salt thereof, wherein Rl, Q, R2, R3, and R4 are as defined in the specification. The invention also provides pharmaceutical compositions comprising a compound of Formula (I), the use of the compounds of Formula (I) as MMP-13 inhibitors |